Cost of preventing variceal rebleeding with transjugular intrahepatic portal systemic shunt and distal splenorenal shunt

Journal of Hepatology

Volumn 48, Issue 3, 2008, Pages 407-414

  Boyer, Thomas D ^a   Henderson, J Michael ^b   Heerey, Adrienne M ^c   Arrigain, Susana ^b   Konig, Vicky ^b   Connor, Jason ^g   Abu Elmagd, Kareem ^h   Galloway, John ^d   Rikkers, Layton F ^e   Jeffers, Lennox ^f  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^g UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^h CARNEGIE MELLON UNIVERSITY   (United States)

Author keywords

Bleeding varices; Cost effectiveness; Shunts; TIPS

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; GASTROINTESTINAL HEMORRHAGE; HEALTH CARE COST; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; OUTPATIENT CARE; PREVENTION AND CONTROL; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SPLENORENAL SHUNT; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; SURVIVAL; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; VARIX BLEEDING;

COST-BENEFIT ANALYSIS; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HUMANS; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; QUALITY-ADJUSTED LIFE YEARS; RECURRENCE; SALVAGE THERAPY; SPLENORENAL SHUNT, SURGICAL; STENTS; TREATMENT OUTCOME;

EID: 38949218426     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2007.08.014     Document Type: Article

References (30)

1. Grace N.D. Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. Am J Gastroenterol 92 (1997) 1081-1091
2. McCormick P.A., and O'Keefe C.O. Improving prognosis following a first variceal haemorrhage over four decades. Gut 49 (2001) 682-685
3. Chalasani N., Kahi C., Francois F., Pinto A., Marathe A., Bini E.J., et al. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol 98 (2003) 653-665
4. Sharara A.I., and Rockey D.C. Gastroesophageal variceal hemorrhage. N Engl J Med 345 (2001) 669-681
5. D'Amico G., Pagliaro L., and Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 22 (1995) 332-353
6. Henderson J.M., Boyer T.D., Kutner M.H., Galloway J.R., Rikkers L.F., Jeffers L.J., et al. Distal splenorenal shunt versus transjugular intrahepatic portal systemic shunt for variceal bleeding: a randomized trial. Gastroenterology 130 (2006) 1643-1651
7. Henderson J.M., Nagle A., Curtas S., Geisinger M., and Barnes D. Surgical shunts and TIPS for variceal decompression in the 1990's. Surgery 128 (1990) 540-547
8. Rikkers L.F. The changing spectrum of treatment for variceal bleeding. Ann Surg 228 (1998) 536-546
9. Jenkins R.L., Gedaly R., Pomposelli J.J., Pomfret E.A., Gordon F., and Lewis W.D. Distal splenorenal shunt: role, indications, and utility in the era of liver transplantation. Arch Surg 135 (1999) 1389-1393
10. Orozco H., and Mercado M.A. The evolution of portal hypertension surgery: lessons from 1000 operations and 50 years' experience. Arch Surg 135 (2000) 1389-1393
11. Boyer T.D., and Haskel Z. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology 41 (2005) 386-400
12. Meddi P., Merli M., Lionetti R., DeSantis A., Valeriano V., Masini A., et al. Cost analysis for the prevention of variceal rebleeding: a comparison between transjugular intrahepatic portosystemic shunt and endoscopic sclerotherapy in a selected group of Italian cirrhotic patients. Hepatology 29 (1999) 1074-1077
13. Russo M.W., Zacks S.L., Sandler R.S., and Brown R.S. Cost-effectiveness analysis of transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic therapy for the prevention of recurrent esophageal variceal bleeding. Hepatology 31 (2000) 358-363
14. Bureau C., Garcia-Pagan J.C., Otal P., Pomier-Layrargues G., Chabbert V., Cortez C., et al. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology 126 (2004) 469-475
15. Rubenstein J.H., Eisen G.M., and Inadomi J.M. A cost-utility analysis of secondary prophylaxis for variceal hemorrhage. Am J Gastroenterol 99 (2004) 1274-1288
16. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost effectiveness in health and medicine. In: Press OU, editor. New York, 1996.
17. Ware Jr. J.E., Kosinski M., Bayliss M.S., McHorney C.A., Rogers W.H., and Raczek A. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care 33 (1995) AS264-AS279
18. Ware Jr. J.E., Kosinski M., Gandek B., Aaronson N.K., Apolone G., Bech P., et al. The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 51 (1998) 1159-1165
19. Ware Jr. J.E., Gandek B., Kosinski M., Aaronson N.K., Apolone G., Brazier J., et al. The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 51 (1998) 1167-1170
20. Brazier J., Usherwood T., Harper R., and Thomas K. Deriving a preference-based single index from the UK SF-36 Health Survey. J Clin Epidemiol 51 (1998) 1115-1128
21. Brazier J., Roberts J., and Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 21 (2002) 271-292
22. Bureau of Labor Statistics. Consumer Price Index http://www.bls.gov, 2004.
23. Briggs A.H., Mooney C.Z., and Wonderling D.E. Constructing confidence intervals for cost-effectiveness ratios: an evaluation of parametric and non-parametric techniques using Monte Carlo simulation. Stat Med 18 (1999) 3245-3262
24. O'Brien B.J., and Briggs A.H. Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods. Stat Methods Med Res 11 (2002) 455-468
25. Gralnek I.M., Jensen D.M., Kovacs T.O.G., Jutabha R., Machicado G.A., Gornbein J., et al. The economic impact of esophageal variceal hemorrhage: cost-effectiveness implications of endoscopic therapy. Hepatology 29 (1999) 44-50
26. Warren W.D., Millikan W.J., Henderson J.M., Wright L., Kutner M., Smith III R.B., et al. Ten years portal hypertensive surgery at Emory. Results and new perspectives. Ann Surg 195 (1982) 530-542
27. Pande N., Resnick R.H., Yee W., Eckardt V.F., and Shurberg J.L. Cirrhotic portal hypertension: Morbidity of continued alcoholism. Gastroenterology 74 (1978) 64-69
28. Younossi Z.M., Guyatt G., Kiwi M., Boparai N., and King D. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut 45 (1999) 295-300
29. Ferrer M., Cordoba J., Garin O., Olive G., Flavia M., Vargas V., et al. Validity of the Spanish version of the chronic liver disease questionnaire (CLDQ) as a standard outcome for quality of life assessment. Liver Transpl 12 (2006) 95-104
30. Gutteling J.J., DeMan R.A., Van Der Plas S.M., Schalm S.W., Busschbach J.J.V., and Darlington A.-S.E. Determinants of quality of life in chronic liver patients. Aliment Pharmacol Ther 23 (2006) 1629-1635